Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
5
×
biotech
boston blog main
cancer
5
×
life sciences
multiple myeloma
5
×
national
national blog main
national top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york blog main
new york top stories
novartis
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
gilead sciences
johnson & johnson
amgen
astrazeneca
biogen
cancer immunotherapy
celgene
cell therapy
What
bio
roundup
blood
conference
ipo
abbvie’s
acquisitions
american
announced
annual
approval
ash
barbecuing
biogen’s
biopharmaceutical
borne
broader
camping
cancer
cancers
cardiologist
center
ceo
check
cholesterol
collabs
companies
company
convo
covid
daniel
day
deal
detect
developing
diego
drug
earlier
failures
files
Language
unset
Current search:
abbvie
×
cancer
×
" multiple myeloma "
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
